Short story of antirheumatic therapy.VIII. The immunodepressants
The use of immunosuppressive drugs in rheumatology is fairly recent, starting just after the Second World War with the introduction of the first alkylating agents in oncohematology. When it became clear that some rheumatic diseases, particularly rheumatoid arthritis and systemic lupus erythematosus,...
Main Authors: | P. Marson, G. Pasero |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2012-03-01
|
Series: | Reumatismo |
Subjects: | |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/542 |
Similar Items
-
Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
by: Kevin Phan, et al.
Published: (2020-11-01) -
Incidence of serious infections in patients with ANCA-associated vasculitis receiving immunosuppressive therapy: A systematic review and meta-analysis
by: Athanasios Vassilopoulos, et al.
Published: (2023-03-01) -
Current and emerging treatment options in the management of lupus
by: Jordan N, et al.
Published: (2016-03-01) -
Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study
by: Khalaf Kridin, et al.
Published: (2021-09-01) -
The use of immunosuppression in autoimmune hepatitis: A current literature review
by: Angela Cropley, et al.
Published: (2017-03-01)